產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-eIF2C2抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-eIF2C2抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-eIF2C2
Cat. Number:
Anti-eIF2C2抗體KL-20459R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Eukaryotic translation Anti-eIF2C2抗體initiation factor 2C (eIF2C) proteins (argonaute family) influence RNA interference (RNAi) as components of the RNA-inducible silencing complex (RISC) or microRNA (miRNA)-containing ribonucleoprotein particle (miRNP). Small RNAs, including small interfering RNAs (siRNAs) and miRNAs, can silence target genes through mechanisms that utilize RISC or miRNP particles. eIF2C1 (argonaute 1, AGO1, eIF2C, GERP95, Q99) and Dicer1 play a coordinated role in siRNA-mediated gene silencing. eIF2C2 (Slicer, argonaute 2, AGO2, Q10) is a RISC component that can concentrate in cytoplasmic processing bodies (P-bodies) and catalyze mRNA cleavage. Mammalian P-bodies contain mRNAs and have an association with miRNA-induced translational silencing and siRNA-induced mRNA degradation. Additional eIF2C proteins include eIF2C3 (argonaute 3, AGO3), eIF2C4 (argonaute 4, AGO4) and meIF2c5 (mouse argonaute 5).
Also known as:
Anti-eIF2C2抗體Ago 2; AGO2_HUMAN; Argonaute 2; Argonaute2; dAgo2; eIF 2C 2; eIF-2C 2; eIF2C 2; Eif2c2; Eukaryotic translation initiation factor 2C 2; hAgo2; MGC3183; PAZ Piwi domain protein; PPD; Protein argonaute-2; Protein slicer; Q10; Slicer protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human eIF2C2.
●
Predicted Molecular Weight: 97kDa.
Storage:
Shipped at 4℃, Anti-eIF2C2抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Anti-eIF2C2抗體Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Anti-eIF2C2抗體Optimal working dilutions must be determined by the end user.
kl478Mu02 心肌肌鈣蛋白I(TNNI3)多克隆抗體 Polyclonal Antibody to Troponin I Type 3, Cardiac (TNNI3)
kl480Mu02 肌紅蛋白(MYO)多克隆抗體 Polyclonal Antibody to Myoglobin (MYO)
kl480Rb51 肌紅蛋白(MYO)多克隆抗體 Polyclonal Antibody to Myoglobin (MYO)
kl482Mu02 內(nèi)皮素1(EDN1)多克隆抗體 Polyclonal Antibody to Endothelin 1 (EDN1)
kl488Hu02 角蛋白5(KRT5)多克隆抗體 Polyclonal Antibody to Keratin 5 (KRT5)
kl500Mu02 嵌套蛋白(NES)多克隆抗體 Polyclonal Antibody to Nestin (NES)
kl512Mu02 纖維介素蛋白(FGL2)多克隆抗體 Polyclonal Antibody to Fibrinogen Like Protein 2 (FGL2)
kl519Ca01 載脂蛋白A1(APOA1)多克隆抗體 Polyclonal Antibody to Apolipoprotein A1 (APOA1)
kl519Mu02 載脂蛋白A1(APOA1)多克隆抗體 Polyclonal Antibody to Apolipoprotein A1 (APOA1)
kl519Si01 載脂蛋白A1(APOA1)多克隆抗體 Polyclonal Antibody to Apolipoprotein A1 (APOA1)
kl524Mu02 組織因子(TF)多克隆抗體 Polyclonal Antibody to Tissue Factor (TF)
kl525Mu02 組織型纖溶酶原激活因子(tPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Tissue (tPA)
kl528Mu01 血小板衍生生長(zhǎng)因子A(PDGFA)多克隆抗體 Polyclonal Antibody to Platelet Derived Growth Factor Subunit A (PDGFA)
kl528Mu02 血小板衍生生長(zhǎng)因子A(PDGFA)多克隆抗體 Polyclonal Antibody to Platelet Derived Growth Factor Subunit A (PDGFA)
kl529Mu02 血栓調(diào)節(jié)蛋白(TM)多克隆抗體 Polyclonal Antibody to Thrombomodulin (TM)
kl531Mu02 纖溶酶原激活物抑制因子2(PAI2)多克隆抗體 Polyclonal Antibody to Plasminogen Activator Inhibitor 2 (PAI2)
